The Israeli based pharmaceutical company D-Pharm announced Wednesday the beginning of their second phase in testing blot clot medication. Authorities in Ukraine have authorized testing on THR-18, which can help people suffering from blot clots and srokes. Vice president of clinical development Dr. Gilad Rosenberg stated, "we are delighted to continue the study of THR-18." He said a test group of thirty patients would help determine the effects. Located at the Kiryat Weizmann Science Park in Rehovot, D-Pharm was founded in 1993.